Improved health‐related quality of life following a randomized controlled trial of alefacept treatment in patients with chronic plaque psoriasis
@article{Feldman2004ImprovedHQ, title={Improved health‐related quality of life following a randomized controlled trial of alefacept treatment in patients with chronic plaque psoriasis}, author={S. Feldman and A. Menter and J. Koo}, journal={British Journal of Dermatology}, year={2004}, volume={150} }
Background Psoriasis has a negative impact on patients' quality of life. Treatment strategies should address both the cutaneous manifestations of the disease and their impact on quality of life.
Topics from this paper
94 Citations
Impact of adalimumab treatment on health‐related quality of life and other patient‐reported outcomes: results from a 16‐week randomized controlled trial in patients with moderate to severe plaque psoriasis
- Medicine
- The British journal of dermatology
- 2008
- 148
Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double‐blind placebo‐controlled trial
- Medicine
- The British journal of dermatology
- 2005
- 119
Effects of briakinumab treatment for moderate to severe psoriasis on health‐related quality of life and work productivity and activity impairment: results from a randomized phase III study
- Medicine
- Journal of the European Academy of Dermatology and Venereology : JEADV
- 2014
- 24
Clinical management decisions are related to the impact of psoriasis on patient‐rated quality of life
- Medicine
- The British journal of dermatology
- 2005
- 34
Ustekinumab improves health‐related quality of life in patients with moderate‐to‐severe psoriasis: results from the PHOENIX 1 trial
- Medicine
- The British journal of dermatology
- 2010
- 57
Patient‐reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial
- Medicine
- The British journal of dermatology
- 2005
- 129
Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate‐to‐severe psoriasis
- Medicine
- Journal of the European Academy of Dermatology and Venereology : JEADV
- 2009
- 96
Clinical effectiveness and safety experience with alefacept in the treatment of patients with moderate‐to‐severe chronic plaque psoriasis in Taiwan: results of an open‐label, single‐arm, multicentre pilot study
- Medicine
- Journal of the European Academy of Dermatology and Venereology : JEADV
- 2008
- 8
How does psoriasis affect quality of life? Assessing an Ingram‐regimen outpatient programme and validating the WHOQOL‐100
- Medicine
- The British journal of dermatology
- 2006
- 29
References
SHOWING 1-10 OF 34 REFERENCES
Intramuscular Alefacept Improves Health-Related Quality of Life in Patients with Chronic Plaque Psoriasis
- Medicine
- Dermatology
- 2003
- 87
Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis‐specific stress
- Medicine
- The British journal of dermatology
- 1997
- 315
The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey.
- Medicine
- Archives of dermatology
- 2001
- 949
- PDF
Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment.
- Medicine
- Dermatologic clinics
- 1996
- 372
The effect of severe psoriasis on the quality of life of 369 patients
- Medicine
- The British journal of dermatology
- 1995
- 510
Psoriasis: current perspectives with an emphasis on treatment.
- Medicine
- The American journal of medicine
- 1999
- 111
The application of multiple quality-of-life instruments in individuals with mild-to-moderate psoriasis.
- Medicine
- PharmacoEconomics
- 1996
- 91